Associate Director/Director, Biostatistics jobs in United States
cer-icon
Apply on Employer Site
company-logo

Beam Therapeutics · 17 hours ago

Associate Director/Director, Biostatistics

Beam Therapeutics is a biotechnology company focused on precision genetic medicines. They are seeking an Associate Director/Director of Biostatistics to lead the statistical strategy for clinical trials and ensure the timely execution of clinical development programs.

BiotechnologyGeneticsMedicalTherapeutics
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Responsible for the statistical strategy for one or more clinical programs/studies and for providing oversight of CRO biometrics deliverables
Support clinical development team to enable robust study design and execution with a focus on innovative and efficient quantitative decision making
Contribute to clinical protocol development, including design evaluations and authoring of protocol statistical sections
Work with study team to develop SAP, data specification, TLF shells, and data monitoring charters etc. and generate TLFs and perform ad hoc analysis as needed
Review CRF design, data management plan, and data transfer plans to ensure data collection meet the trial objectives and requirements of statistical analyses
Specify randomization schedules and test their implementations as needed
Contribute to the review and interpretation of data analyses from clinical trials and to the development of CSRs, regulatory documents and support publications, manuscripts, posters and abstracts
Support regulatory submissions and interactions with regulatory agencies
Provide requirements and oversight to statistical programmers
Works collaboratively and communicates effectively with Statistical programming, Data Management, clinical operations, clinical development, Regulatory and other functions

Qualification

Ph.D. in statistics/biostatisticsStatistical methods for clinical trialsSAS programmingR programmingStatistical simulationsBayesian statistical designFDAICH regulationsData standards CDASHData standards SDTMData standards ADaMManage timelinesCommunication skillsCross-functional collaborationSelf-motivated

Required

Ph.D. in statistics or biostatistics with a minimum of 7 years' post-doctoral experience in pharmaceutical/biotech industry with prior project leadership or equivalent experience
In-depth knowledge of statistical methods and trial designs for rare disease and/or gene and cell therapy clinical trials
Proficient in SAS and R programming
Strong knowledge of data standards, including CDASH, SDTM, and ADaM
Must be self-motivated, and able to work independently and effectively with colleagues and vendors and demonstrate excellent verbal and written communication skills
Ability to prioritize and manage timelines and shifting priorities within a fast-paced company environment
Ability to build cross-functional relationships and work collaboratively across functions

Preferred

Extensive experience in statistical simulations, Bayesian statistical design and analysis and experience in observational studies and/or real world data (RW) are desirable
Extensive experience in NDA/BLAs, MAAs and other regulatory interactions preferred
Strong knowledge of FDA and ICH regulations and guidelines, experience and knowledge of gene/cell therapy are desirable

Company

Beam Therapeutics

twittertwittertwitter
company-logo
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

H1B Sponsorship

Beam Therapeutics has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (9)
2023 (12)
2022 (9)
2021 (7)
2020 (4)

Funding

Current Stage
Public Company
Total Funding
$1.19B
2025-03-10Post Ipo Equity· $500M
2021-01-19Post Ipo Equity· $260M
2020-02-11Post Ipo Equity· $207M

Leadership Team

leader-logo
John Evans
CEO
linkedin
leader-logo
Christine Bellon
Chief Legal Officer
linkedin
Company data provided by crunchbase